GeneInCell podcast

Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026

15/06/2026
0:00
57:13
Reculer de 15 secondes
Avancer de 15 secondes

Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to reduce harmful protein production, reshape splicing, and open new possibilities for precision therapeutics. We cover the history, mechanism, chemistry, and growing clinical relevance of ASOs, along with their promise and limitations in treating genetic, neurological, retinal, muscular, liver, and rare diseases.


D'autres épisodes de "GeneInCell"